Cascade Screening and Treatment Initiation in Young Adults with Heterozygous Familial Hypercholesterolemia

Heterozygous familial hypercholesterolemia (HeFH) creates elevated low-density lipoprotein cholesterol (LDL-C), causing premature atherosclerotic cardiovascular disease (ASCVD). Guidelines recommend cascade screening relatives and starting statin therapy at 8–10 years old, but adherence to these rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Peterson, Amy L., Bang, Matthew, Block, Robert C., Wong, Nathan D., Karalis, Dean G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306062/
https://www.ncbi.nlm.nih.gov/pubmed/34300259
http://dx.doi.org/10.3390/jcm10143090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306062/
https://www.ncbi.nlm.nih.gov/pubmed/34300259
http://dx.doi.org/10.3390/jcm10143090

Ejemplares similares